View this email in your browser
Watch PRI's Evan Harris on Newsy TV 
NCAA Will Let Student Athletes Profit Off Their Names, Images, and Likenesses
 
Newsy TV | Adam Elrashidi
October 29, 2019

. . . Tuesday’s ruling marks a 180 from how the NCAA addressed this issue just a month ago, when it called California’s Fair Pay to Play Act “unconstitutional.” The NCAA said at the time that such rules would give some schools an “unfair” recruiting advantage, and that those schools would be barred from competition.

So, what changed? One expert summed it up in one word: money. Evan Harris of the Pacific Research Institute, a free-market policy think tank, told Newsy California had “called the NCAA’s bluff” over the state’s lucrative sports market.
 
Listen to PRI's "Next Round" Podcast

Siskind vs. Siskind - Father and Daughter Face-Off on the Issues
October 29, 2019

Sarah Rose Siskind, a New York writer and aspiring comedienne and Larry Siskind, Bay Area attorney, father and daughter, go head to head on the issues of the day: climate change, socialism, the presidential race, technology and the changing culture of work, the generational divide, and the meaning of the American Dream.

Trump's Executive Order Strengthens Medicare in Face of 'Medicare-for-All' Threat
South Florida Sun-Sentinel | Sally C. Pipes
October 29, 2019

Earlier this month, President Trump signed an executive order designed to defend Medicare against the threat of “Medicare-for-all.” Speaking to a crowd in The Villages, Florida, the president promised that his order would “strengthen, protect, and defend Medicare for all of our senior citizens.”
We Need a Cure for the Arrogance of Drug Price Control Advocates
Forbes.com | Wayne Winegarden
October 29, 2019

"Three hundred forty-five billion dollars in savings versus the cost of eight to 15 fewer drugs over 10 years, I frankly think it’s worth it.”

Rep. Darren Soto (D-FL), hearing before the House Energy and Commerce Committee

In the above quote, Representative Soto is defending H.R. 3, the drug price control bill Speaker Nancy Pelosi is advocating. While the Congressman believes that the costs of price controls are “worth it”, patients living with diseases that lack an effective treatment may disagree.